Andrew M. Perez, MD
- 2Articles
- 16.6KReads1
- 2011–2014Active
- 9Collaborators
- 230Citations2
About
Andrew M. Perez, MD, has contributed to research on treatment-resistant depression, focusing on the safety, tolerability, and clinical outcomes of ketamine in this condition. His publications in Psychiatrist.com include studies examining ketamine’s use in acute treatment courses and sustained remission cases. Collaborators frequently include Dennis S. Charney, James W. Murrough, and Sanjay J. Mathew.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
